Steven B. Porter

A double blind, randomized, placebo-controlled study of SP-303 (Provir) in the symptomatic treatment of acute diarrhea among travelers to Jamaica and Mexico

Herbert L. DuPont, Daniel DiCesare, John J. Mathewson, 2002 .

Treatment of chronic hepatitis C patients with the NS3/4A protease inhibitor danoprevir (ITMN-191/RG7227) leads to robust reductions in viral RNA: a phase 1b multiple ascending dose study.

Dominique Larrey, Stefan Zeuzem, Alain Patat, 2011, Journal of hepatology.